急性拉莫特里金过量剂 (ATOM-10) 的临床影响
Angela L Chiew1,2,3, Geoffrey K Isbister1,4, Kiet Nguyen2,3
1New South Wales Poisons Information Centre, Children's Hospital at Westmead, Westmead, New South Wales, Australia.
Clinical toxicology (Philadelphia, Pa.)
|March 24, 2025
概括
拉莫因过量服用可能会导致严重的毒性,包括昏迷和发作,这取决于度. 当与其他血清激素药物同时摄入时,无论拉莫特里金水平如何,血清激素毒性是常见的.
科学领域:
- 临床毒理学 临床毒理学
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
背景情况:
- 拉莫特里金过量服用通常被认为具有低毒性.
- 然而,有史以来有报道过严重的毒性和血清毒性.
研究的目的:
- 调查急性拉莫特里金过量剂的临床影响和结果.
- 为了确定lamotrigine度和毒性之间的关系.
- 评估拉莫特里金过量服用中血清素毒性的发生率和特征.
主要方法:
- 对14岁以上的急性拉莫特里金过量 (摄入≥2g) 患者进行前性观察性研究.
- 收集的数据包括临床特征,拉莫特里金度,管理和结果.
- 分析拉莫特里金度与严重结果之间的相关性.
主要成果:
- 包括54名患者;中位摄入剂量为4.8g,其中76%同时摄入其他物质.
- 常见的副作用包括镇静 (81%),低心率 (72%),低血压 (39%) 和发作 (20%).
- 血清素毒性发生在43%的患者中,在那些同时摄入血清素药物的人群中显著高 (67%vs5%).
- 较高的拉莫特里金度与昏迷相关,低血压需要内和发作.
结论:
- 拉莫特里金过量毒性,包括昏迷,和低血压,是度依赖的.
- 血清激素毒性经常在与其他血清激素药物同时服用的患者中观察到,与lamotrigine度无关.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
138
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
138
Local Anesthetics: Adverse Effects
378
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
378
Antiepileptic Drugs: Glutamate Antagonists
264
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
264
Mania and Antimanic Drugs: Overview
106
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
106
Toxic Reactions: Overview
920
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
920
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
206
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
206


